Cargando…

Immunotherapy of distant metastatic disease

Immunotherapy of metastatic melanoma consists of various approaches leading to specific or non-specific immunomodulation. The use of FDA-approved interleukin (IL)-2 alone, in combination with interferon α, and/or with various chemotherapeutic agents (biochemotherapy) is associated with significant t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schadendorf, D., Algarra, S. M., Bastholt, L., Cinat, G., Dreno, B., Eggermont, A. M. M., Espinosa, E., Guo, J., Hauschild, A., Petrella, T., Schachter, J., Hersey, P.
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712591/ https://www.ncbi.nlm.nih.gov/pubmed/19617297 http://dx.doi.org/10.1093/annonc/mdp253

Ejemplares similares

Small molecules and targeted therapies in distant metastatic disease
por: Hersey, P., et al.
Publicado: (2009)

Biomarkers in melanoma
por: Gogas, H., et al.
Publicado: (2009)

Utility of adjuvant systemic therapy in melanoma
por: Eggermont, A. M. M., et al.
Publicado: (2009)

Surgery and radiotherapy in the treatment of cutaneous melanoma
por: Testori, A., et al.
Publicado: (2009)

Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy
por: Tolstrup, Lærke K., et al.
Publicado: (2019)

Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences
por: Tolstrup, Lærke K, et al.
Publicado: (2020)

Maintenance treatment with chemotherapy and immunotherapy in non-small cell lung cancer: a case report
por: Llanos, Anabella, et al.
Publicado: (2012)

A Full GMP Process to Select and Amplify Epitope-Specific T Lymphocytes for Adoptive Immunotherapy of Metastatic Melanoma
por: Labarriere, N., et al.
Publicado: (2013)

The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial
por: Tolstrup, Lærke K., et al.
Publicado: (2020)

Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma
por: Sallinen, H., et al.
Publicado: (2019)

Radiotherapy in patients with distant metastatic breast cancer
por: Steinauer, Kirsten, et al.
Publicado: (2014)

Radiotherapy may augment response to immunotherapy in metastatic uveal melanoma patients
por: Grynberg, Shirly, et al.
Publicado: (2022)

Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
por: Collins, Dearbhaile Catherine, et al.
Publicado: (2020)

Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience
por: Asher, Nethanel, et al.
Publicado: (2021)

Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial
por: Guo, J., et al.
Publicado: (2017)

Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread
por: Ma, Qiaoli, et al.
Publicado: (2018)

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study
por: Gutzmer, R, et al.
Publicado: (2016)

Rare Distant Metastatic Disease of Ovarian and Peritoneal Carcinomatosis: A Review of the Literature
por: Thomakos, Nikolaos, et al.
Publicado: (2019)

Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
por: Collins, Dearbhaile Catherine, et al.
Publicado: (2021)

Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma
por: Carlino, M S, et al.
Publicado: (2014)

Evaluation of the 2015 ATA Guidelines in Patients With Distant Metastatic Differentiated Thyroid Cancer
por: van Velsen, Evert F S, et al.
Publicado: (2019)

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe
por: Becker, Jürgen C., et al.
Publicado: (2017)

Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice
por: Meyblum, Louis, et al.
Publicado: (2023)

Distant metastatic retinoblastoma without central nervous system involvement
por: Ali, Mohammad Javed, et al.
Publicado: (2013)

JUNB suppresses distant metastasis by influencing the initial metastatic stage
por: Wutschka, Juliane, et al.
Publicado: (2021)

Ectopic papillary thyroid carcinoma mimicking distant metastatic tissue
por: Qi, Yingsong, et al.
Publicado: (2022)

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy
por: Herbreteau, Guillaume, et al.
Publicado: (2018)

Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives
por: Middleton, Mark R., et al.
Publicado: (2020)

Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
por: Bansal, Dhruv, et al.
Publicado: (2021)

Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer
por: Su, Chloe C., et al.
Publicado: (2023)

Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study
por: Herbreteau, Guillaume, et al.
Publicado: (2021)

Distant myonecrosis by atraumatic Clostridium septicum infection in a patient with metastatic breast cancer
por: Gray, Kelsey M., et al.
Publicado: (2020)

Metastatic lymph node in gastric cancer; Is it a real distant metastasis?
por: Lim, Do Hyoung, et al.
Publicado: (2010)

Prevalence and prognosis of synchronous distant metastatic tonsil squamous cell carcinomas
por: Li, Yujiao, et al.
Publicado: (2021)

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
por: Nyakas, M., et al.
Publicado: (2019)

Epidemiology of invasive cutaneous melanoma
por: MacKie, R. M., et al.
Publicado: (2009)

Combined targeted therapy and immunotherapy in the treatment of advanced melanoma
por: Wilmott, James S., et al.
Publicado: (2012)

Staging of cutaneous melanoma
por: Mohr, P., et al.
Publicado: (2009)

The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction
por: Valkema, M. J., et al.
Publicado: (2022)

Immunotherapy in non-melanoma skin cancer: updates and new perspectives
por: Ascierto, Paolo Antonio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0n2rhjeug052qe2ebs21l6p5cd